Good morning :)
Place Order
Add to Watchlist

Global Health Ltd

MEDANTA

Global Health Ltd

MEDANTA
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹28,674 cr, stock is ranked 268
Moderate RiskStock is 2.72x as volatile as Nifty
1,067.751.59% (-17.30)
1,067.751.59% (-17.30)

Price Chart

High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹28,674 cr, stock is ranked 268
Moderate RiskStock is 2.72x as volatile as Nifty
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Avg

Financials growth has been moderate for a few years

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹28,674 cr, stock is ranked 268
Moderate RiskStock is 2.72x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
59.4410.07—
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.356.540.51%

Forecast & Ratings

Detailed Forecast 
56%
Analysts have suggested that investors can buy this stock

from 9 analysts

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Global Health Limited, formerly Global Health Private Limited, is an India-based company. The Company is a tertiary care provider operating in the North and East regions of India. The Company operates approximately four hospitals under Medanta brand

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Lower than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 9.61%, vs industry avg of 10.02%

Decreasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 4.11% to 3.86%

Lower than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 41.81%, vs industry avg of 42.9%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue1,439.861,344.001,392.141,505.821,515.631,255.751,800.002,021.132,382.883,438.27
Raw Materialssubtract323.98287.89313.43324.92319.21301.73451.23459.11540.962,555.64
Power & Fuel Costsubtract29.2230.6329.5530.6531.1127.4331.8036.8435.86
Employee Costsubtract472.67518.07526.60540.72522.30415.91494.66532.91591.06
Selling & Administrative Expensessubtract140.90170.86211.56244.28116.95271.25327.42411.71488.02
Operating & Other expensessubtract118.55151.10137.01156.91264.0238.1679.06110.94120.75
Depreciation/Amortizationsubtract71.5777.3586.3690.6998.5787.6487.1786.0987.09178.96
Interest & Other Itemssubtract16.5319.0523.5621.1332.5429.2032.8331.8230.4673.98
Taxes & Other Itemssubtract91.5134.7026.7433.5828.1827.1477.0488.46127.78147.25
EPS7.212.241.532.574.172.328.7310.1013.4517.97
DPS0.000.000.000.000.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.000.000.000.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2023

Annual report

PDF

Investor Presentation

Feb 13PDF
FY 2024

Annual report

PDF

Investor Presentation

Aug 10PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CareHospitals & Diagnostic Centres

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Global Health Ltd79.4510.07—
Apollo Hospitals Enterprise Ltd118.7514.580.22%
Max Healthcare Institute Ltd99.2012.480.14%
Fortis Healthcare Ltd78.255.480.16%

Price Comparison

Compare MEDANTA with any stock or ETF
Compare MEDANTA with any stock or ETF
MEDANTA
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding33.04%9.59%1.52%12.20%43.65%

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Shareholding History

JunSepDec '23MarJunSep10.58%10.69%11.36%12.09%12.94%12.20%

Mutual Funds Holding Trend

Mutual Fund Holding

Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

Top 5 Mutual Funds holding Global Health Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
Kotak Emerging Equity Fund - Growth - Direct Plan

Growth
2.5416%1.44%0.29%57/75 (-3)
Canara Robeco Emerging Equities - Growth - Direct Plan

Growth
0.7964%0.95%-0.05%62/96 (0)
UTI Flexi Cap Fund - Growth - Direct Plan

Growth
0.7576%0.84%0.41%52/70 (+13)

Compare 3-month MF holding change on Screener

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

MEDANTA has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

Dividends

Hmm, looks like data is unavailable here. Please come back after some time
News & Opinions
Corporate
Global Health announces board meeting date

Global Health will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live

2 days agoCapital Market - Live
Corporate
Medanta signs O&M agreement for 750 bed hospital in Pitampura, New Delhi

Global Health announced that the Company has signed an Operations and Management Agreement with Dr. Narayan Dutt Shirmali Foundation International Charitable Trust Society (Society) to operate and manage a ~750 bed super specialty hospital in Pitampura, New Delhi. The hospital is expected to commence operations in ~4 years, subject to necessary statutory and customary approvals. As per the agreement, the hospital building and associated civil infrastructure will be developed by the Society and Medanta will make the necessary investments in internal fitouts, MEP, furniture and medical equipment. Medanta is expected to incur a project capex of ~Rs. 600 crores in next 3-4 years, to be funded by a combination of internal accruals and debt financing. Medanta will have full control over the day to day running of the hospital. The agreement is for an initial term of 30 years, further extendable on mutually agreeable terms. The hospital will be located on a 7-acre site in Pitampura, New Delhi, with a total builtup area of 7.6 Lakh sq.ft excluding the basement. The site offers good connectivity to the Outer Ring road and is in close proximity to high-density residential areas, which will enable Medanta to serve the region's growing healthcare needs. The state-of-the-art ~750 bedded super-specialty hospital will cater to over 30 super specialties including cardiac, neurosciences, cancer, orthopaedics, digestive, hepatobiliary sciences, multispecialty robotic surgeries, regenerative medicine, as well as full range of transplants. Powered by Capital Market - Live

4 days agoCapital Market - Live
Corporate
Global Health schedules AGM

Global Health announced that the 20th Annual General Meeting (AGM) of the company will be held on 19 September 2024.Powered by Capital Market - Live

2 months agoCapital Market - Live
Earnings
Global Health consolidated net profit rises 4.20% in the June 2024 quarter

Net profit of Global Health rose 4.20% to Rs 106.29 crore in the quarter ended June 2024 as against Rs 102.01 crore during the previous quarter ended June 2023. Sales rose 10.45% to Rs 861.08 crore in the quarter ended June 2024 as against Rs 779.58 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales861.08779.58 10 OPM %21.6423.66 - PBDT190.27181.43 5 PBT143.65141.04 2 NP106.29102.01 4 Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Global Health to table results

Global Health will hold a meeting of the Board of Directors of the Company on 8 August 2024.Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Global Health acquires land for purpose of building 500-bed hospital in Mumbai

Global Health has been offered by Mumbai Housing and Area Development Authority (MHADA) vide its letter dated 22 July 2024 a land parcel measuring 8859.24 sq. meters for an amount of Rs 125.11 crores (approx.) on lease basis under online e-tenders issued by MHADA. The aforesaid land parcel is situated at Mauje-Oshiwara, Jogeshwari, CTS No. 31, 32 (part), 33 (part), 37 (part), Mumbai, Maharashtra and can accommodate construction of a 500+ bedded hospital with an estimated project capex of Rs. 1,200 crore, subject to various customary and statutory approvals. The detailed business plan for the construction of above mentioned 500+ bedded hospital is subject to approval of Board of the Company and the Company will update the stock exchanges on any material developments relating to this matter. Powered by Capital Market - Live

3 months agoCapital Market - Live

Reliance Infrastructure Ltd leads losers in ‘A’ group

4 months agoBusiness Standard
Seasonal Dip In Occupancies Due To Festivities In Mature Hospitals: Medanta Q3 Conf Call | CNBC TV18
8 months agoCNBC-TV18